Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  PI3K alpha inhibitor MLN1117
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
Docetaxel With or Without MLN1117 in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MLN1117-1501, NCI-2015-00520, 2014-004281-25, U1111-1160-1736, NCT02393209
Dose Escalation Study of MLN1117 in Subjects With Advanced Cancer
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: INK1117-001, NCI-2011-03520, NCT01449370
Phase 1b Study of MLN0128 in Combination With MLN1117 in Adult Patients With Advanced Nonhematologic Malignancies
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: C32001, NCI-2014-01567, 2013-000466-11, NCT01899053
Start Over